February 23, 2017 – Courtagen Receives Notice of Allowance for a Genetically Targeted Pain Therapy Patent in the U.S. Patent targets personalized medicine approach matching genetic markers for chronic pain with therapeutic drugs, including the cannabis-derived compound cannabidiol
February 10, 2017 – CannMed 2017 Conference Announces Expanded Speaker List for Medical Cannabis Health and Research Conference to be Held in Boston in April Leaders in Cannabis Medicine and the Medical Cannabis Industry Join Presenters Including Dr. Raphael Mechoulam, Pioneering Israeli Scientist Known as “The Father of Marijuana Research”
February 3, 2017 – Medicinal Genomics Hosts CannMed 2017 Conference in Boston with Hawaiian Connection International conference at Harvard organized by Manoa Valley resident helps to educate physicians about use of medical cannabis
January 25, 2017 – Medicinal Genomics Receives NIDA Grant to Develop Novel Toxin Detection Test for Medical Cannabis Test development will center around detecting presence of toxic products left behind by rogue molds and bacteria on medical cannabis.
January 12, 2017 – CannMed 2017 Conference to Offer Doctors an Opportunity to Earn CME Credits to Learn About Cannabis Medicine Courtagen and TheAnswerPage partner to provide continuing medical education about the endocannabinoid system and medical cannabis for the CannMed 2017 Personalized Cannabinoid Medicine Conference.
January 9, 2017 – Veterans for Cannabis Foundation and Medicinal Genomics Pair Up to Tackle Medical Marijuana “Strain Name Game” for Vets MGC will provide StrainSEEK® strain identification and registration services for VFCF’s branded products and help promote the VFCF mission as MGC’s exclusive veteran’s cannabis support partner.
December 1, 2016 – Medicinal Genomics and Courtagen Life Sciences Announce CannMed 2017, the Personalized Cannabinoid Medicine Conference, April 9-11, 2017 The 2nd annual CannMed 2017 Conference will convene leaders in research, medicine, and therapeutics to discuss cannabis-based therapies for cancer, and neurological and inflammatory disorders, and developments in cannabis genetics and safety.
November 15, 2016 – Researchers Find Alarming Pathogenic Contamination Inaccuracies with Commonly Used Culture-Based Cannabis Testing Methods Medicinal Genomics (MGC) and Courtagen Life Sciences today announced the publication of a new research study that identifies several significant shortcomings of traditional culture-based safety testing methods for yeast and mold in the Cannabis industry.
October 6, 2016 – Medicinal Genomics Partners with Industry Leaders to Ensure the Safety and Effectiveness of Medical Cannabis Medicinal Genomics, an innovative molecular information company focused on safety, research, and genetics of therapeutic plants, is partnering with a preliminary group of twelve leading cultivators and processors to develop fully-validated, genomics-based safety and quality standards for medical cannabis.
April 20, 2016 – Medicinal Genomics Revolutionizes Cannabis Industry with Introduction of Strain ID & Certification Service Medicinal Genomics Corporation today announced StrainSEEK®, a revolutionary genetics based service designed to identify and certify cannabis and hemp strains, providing growers with the identity, heritage, and chemistry of the cannabis and hemp plants they are cultivating.
April 6, 2016 – CannMed 2016 Conference to be Live Streamed Including the Keynote Speech by Noted Israeli Marijuana Research Pioneer Dr. Raphael Mechoulam Medicinal Genomics and Courtagen Life Sciences today announced that the entire full day program of CannMed 2016 will be live streamed on Monday, April 11th, 2016.
March 15, 2016 – Dr. Raphael Mechoulam to Receive Lifetime Achievement Award at CannMed 2016 Conference in Cambridge, MA in April Pioneering Israeli Scientist Known as “The Father of Marijuana Research,” Dr. Raphael Mechoulam, to be Honored for Decades of Discoveries.